Metabolic effects of vasoactive agents

Current Opinion in Anaesthesiology

Volumn 14, Issue 2, 2001, Pages 157-163

  Trager K ^a   Radermacher, P ^a   DeBacker, D ^a   Vogt, J ^a   Jakob, S ^a   Ensinger, H ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADRENALIN; ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE; DOPAMINE; DOPEXAMINE; ENOXIMONE; FENOTEROL; INOTROPIC AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; PHENYLEPHRINE; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN; VASOACTIVE AGENT;

BLOOD VOLUME; ENDOTOXEMIA; GLUCONEOGENESIS; HEMODYNAMICS; HYPOVOLEMIC SHOCK; METABOLISM; OXYGEN TRANSPORT; PERFUSION; PRIORITY JOURNAL; RESUSCITATION; REVIEW; VASOCONSTRICTION; VASODILATATION;

EID: 0035076111     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200104000-00006     Document Type: Review

References (61)

1. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis
2. The effect of adrenaline and noradrenaline on hepatic blood flow and splanchnic carbohydrate metabolism in man
3. 2-agonists
4. Impaired β-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: Association with myocardial hyporesponsiveness to catecholamines
5. Optimizing gastric mucosal perfusion: All catecholamines may not be created equal
6. Role of gluconeogenesis in epinephrine-stimulated hepatic glucose production in humans
7. 2 and metabolism transient?
8. Relationship between infusion rates, plasma concentrations, and cardiovascular and metabolic effects during the infusion of norepinephrine in healthy volunteers
9. Effect of epinephrine on amino acid and energy metabolism in humans
10. Glucose and urea production and leucine, ketoisocaproate and alanine fluxes at supraphysiological plasma adrenaline concentrations in volunteers
11. Role of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscle
12. Effects of norepinephrine, epinephrine, and dopamine infusions on oxygen consumption in volunteers
13. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man
14. Epinephrine impairs splanchnic perfusion in septic shock
15. Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction
16. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: A prospective randomized study
17. From tissue perfusion to metabolic marker: Assessing organ Competition and co-operation in critically ill patients
18. Splanchnic blood flow is greater in septic shock treated with norepinephrine than in severe sepsis
19. Regional blood flow and oxygen transport in septic shock
20. Effect of vasoactive treatment on the relationship between mixed venous and regional oxygen saturation
21. Effects of perfusion pressure on tissue perfusion in septic shock
22. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis
23. 2 exchange and energy balance
24. 2 exchange and energy balance
25. Impact of exogenous β-adrenoceptor stimulation on hepato-splanchnic oxygen kinetics and metabolic activity in septic shock
26. Increasing splanchnic blood flow in the critically ill
27. The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock
28. The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients
29. Oxygen uptake and metabolic changes during infusion of dobutamine in comparison to fenoterol and phenylephrine in volunteers
30. Different dosages of dobutamine in septic shock patients: Determining oxygen consumption with a metabolic monitor integrated in a ventilator
31. 2 relationship: How to get rid of methodological pitfalls?
32. 2 dependency exist in critically ill septic patients?
33. Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock
34. Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock
35. Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock
36. Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock
37. A dobutamine test can disclose hepatosplanchnic hypoperfusion in septic patients
38. Effects of dobutamine on gastric mucosal perfusion and hepatic metabolism in patients with septic shock
39. Effect of dobutamine on splanchnic carbohydrate metabolism and amino acid and lactate balance after cardiac surgery
40. Metabolic and calorigenic effects of dopexamine in healthy volunteers
41. Protecting the gut and the liver in the critically ill: Effects of dopexamine
42. Abnormalities of gastric mucosal oxygenation in septic shock-partial responsiveness to dopexamine
43. Effect of a dopexamine-induced increase in cardiac index on splanchnic hemodynamics in septic shock
44. Effect of a dopexamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock
45. Dopexamine increases splanchnic blood flow but decreases gastric mucosal pH in severe septic patients treated with dobutamine
46. 2): New aspects of an old substance in the treatment of critically ill patients
47. The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients
48. The effect of prostacyclin on gastric mucosal pH in patients with septic shock
49. Prostacyclin improves glucose utilization in patients with sepsis
50. Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock
51. From mucolytic to antioxidant and liver protection: New aspects in the intensive care unit career of N-acetylcysteine
52. N-acetylcysteine preserves oxygen consumption and gastric mucosal pH during hyperoxic ventilation
53. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: Results from a prospective, randomized, double-blind study
54. N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: Results of a prospective, randomized, double-blind study
55. Effects of nitric oxide in septic shock
56. Multi-center, randomized, placebocontrolled, double blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock
57. An open-label close escalation study of the nitric oxide synthase inhibitor N-methyl-L-arginine hydrochloride (546C88) in patients with septic shock
58. 2-exchange and energy metabolism during hyperdynamic porcine endotoxemia
59. Excessive NO production does not account for the inhibition of hepatic gluconeogenesis in endotoxemia
60. Improvement of tissue oxygenation with enoximone in septic shock
61. Metabolic and haemedynamic response to the phosphodiesterase-III-inhibitor eneximone in septic patients